Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion description "[High iASPP expression was significantly associated with clear cell carcinoma subtype (P = 0.003), carboplatin and paclitaxel chemoresistance (P = 0.04), shorter overall (P = 0.003), and disease-free (P = 0.001) survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion evidence source_evidence_literature NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion SIO_000772 21926165 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion wasDerivedFrom befree-20150227 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_assertion wasGeneratedBy ECO_0000203 NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP853675.RA8-uup7RVoZcI1g0BrdSErak_ReiOVm5d1vaEjOcGTvI130_provenance.